New Delivery Mechanism for pharmaceutical medication without systematic side effects.
Direct Effects is a patented new drug delivery system. This new pharmaceutical drug delivery is for neuropathic pain relief and many other issues. It is not a transdermal system, but topical. It is applied to target the afferent nerve on the back of the neck without the product getting into the bloodstream.
This prevents systemic toxicity. Having no addiction characteristics, leaves this delivery mechanism and process the method of choice for practitioners looking for an effective crossover to typical prescribing methodologies. With current stringent regulations with many of these medications, this is the optimum.
Patented Custom Topical Formulations for Neuro-Psychiatric disorders, such as:
Migraines, cluster headaches, Anxiety, Diabetic Peripheral Neurophy (DPN), Parkinsons, MS, neuropathic pain, Spasticity/Gait, Tremors and ADD/ADHD
Now Neuro-Psychiatric medications comes in a revolutionary topical delivery system for non-systemic and customizable patient care.
Topical Regional Neuro-Affective (TRNA) Therapy is:
- A non systemic drug
- Formulated as a topical cream
- Compounded in a dermal penetration enhancing medium
- Applied to the BONATH region (Back of the Neck at the Hairline)
Direct Effects is a patented new drug delivery system. This new pharmaceutical drug delivery is for neuropatic pain relief and many other issues.
Dr. Ronald Aung-DinPatent holder
Dr. Aung-Din has practiced General Neurology and Neuro-Psychiatry in Sarasota, Florida for over 25 years. He is board-certified by the American Board of Psychiatry and Neurology and a member of the American Academy of Neurology.
- None Systemic
- No Physical Addiction
- No Renal Compromise
- No Phepatic Toxicity
- No Half-Life Issues
- No Limited Response Time
- Easy Non-Toxic Start-Up